PAVmed (PAVM) Research & Development (2015 - 2026)
PAVmed (PAVM) reported Research & Development of $2.07 million for Q2 2026, up 161.6% from $790,000 a year earlier.
Powered by 
Analysis
PAVmed (PAVM) Research & Development (2015 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, PAVmed's Research & Development came in at $5.77 million, up 43.4% year-over-year; for FY2025, it was $4.49 million, down 24.3% from FY2024.
- Research & Development has declined for three consecutive years, with a five-year compound annual growth rate of -16.3% (FY2020 to FY2025).
- By year, Research & Development came in at $5.93 million in FY2024 (-58.4%), $14.28 million in FY2023 (-43.7%), $25.34 million in FY2022 (+27.7%) and $19.85 million in FY2021 (+81.0%).
- The Q2 2026 figure ranks as the highest quarterly Research & Development since Q4 2023.
- Year over year, Research & Development gained in two of the last five quarters, with growth averaging 19.9%.
- The high point for year-over-year Research & Development in five years was Q2 2026 (growth of 161.6%); the low point was Q4 2024 (a decline of 77.6%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 250.84 Bn | 229.99 Bn | 4.88 Bn | 364.00 Mn |
| 2 | Abbott Laboratories | 174.73 Bn | 145.82 Bn | 7.27 Bn | 892.00 Mn |
| 3 | Danaher | 159.85 Bn | 143.67 Bn | 3.61 Bn | 412.00 Mn |
| 4 | Intuitive Surgical | 146.79 Bn | 126.35 Bn | 1.96 Bn | 370.60 Mn |
| 5 | Medtronic | 114.54 Bn | 80.41 Bn | 6.34 Bn | 771.00 Mn |
| 6 | Stryker | 105.67 Bn | 91.79 Bn | 4.50 Bn | 434.00 Mn |
| 7 | Boston Scientific | 63.93 Bn | 58.94 Bn | 3.85 Bn | 554.00 Mn |
| 8 | Becton Dickinson | 50.12 Bn | 47.27 Bn | 2.32 Bn | 258.00 Mn |
| 9 | Edwards Lifesciences | 50.06 Bn | 34.17 Bn | 1.35 Bn | 278.90 Mn |
| 10 | PAVmed | 90.10 Mn | 61.93 Mn | -89,000.00 | 2.07 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.07 Mn |
| Dec 31, 2025 | 1.83 Mn |
| Sep 30, 2025 | 1.09 Mn |
| Jun 30, 2025 | 790,000.00 |
| Mar 31, 2025 | 787,000.00 |
| Dec 31, 2024 | 807,000.00 |
| Jun 30, 2024 | 1.64 Mn |
| Mar 31, 2024 | 1.94 Mn |
| Dec 31, 2023 | 3.60 Mn |
| Sep 30, 2023 | 3.16 Mn |
| Jun 30, 2023 | 3.47 Mn |
| Mar 31, 2023 | 4.05 Mn |
| Dec 31, 2022 | 6.67 Mn |
| Sep 30, 2022 | 6.20 Mn |
| Jun 30, 2022 | 6.74 Mn |
| Mar 31, 2022 | 5.93 Mn |
| Dec 31, 2021 | 6.97 Mn |
| Sep 30, 2021 | 5.31 Mn |
| Jun 30, 2021 | 4.26 Mn |
| Mar 31, 2021 | 3.32 Mn |
API Access
PAVmed Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=PAVM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "PAVM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=PAVM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();